Skip to main content

Avestar Capital, LLC

Position in JNJ — Johnson & Johnson

CIK 1704404 New York, NY

Position in JNJ

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$4,757,366
+$108,607 QoQ
Shares Held
18,732
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#1,653
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Dec 31, 2021
CallValue
$0
CallShares
0
PutValue
$1,710,700
PutShares
10,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Avestar Capital, LLC holds $29,224,901 across 12 Drug Manufacturers - General names. JNJ ranks #2 (16.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 JNJ
Johnson & Johnson
This page
18,732 $4,757,366

All Filings in JNJ

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,757,366 18,732
2026-03-31 $4,648,759 19,018
2025-12-31 $3,895,626 18,824
2025-09-30 $3,287,682 17,731
2025-06-30 $2,528,012 16,550
2025-03-31 $2,464,050 14,858
2024-12-31 $1,661,828 11,491
2024-09-30 $2,121,365 13,090
2024-06-30 $1,604,836 10,980
2024-03-31 $1,978,007 12,504
2023-12-31 $1,303,920 8,319
2023-09-30 $1,104,890 7,094
2023-06-30 $1,047,907 6,331
2023-03-31 $1,614,325 10,415
2022-12-31 $2,186,220 12,376
2022-09-30 $1,790,425 10,960
2022-06-30 $1,747,585 9,845
2022-03-31 $1,796,048 10,134
2021-12-31 $1,710,700 10,000
2021-12-31 $1,601,899 9,364
2021-09-30 $1,615,000 10,000
2021-09-30 $1,615,807 10,005
2021-06-30 $1,671,946 10,149
2021-03-31 $1,445,129 8,793
2020-12-31 $1,400,996 8,902
2020-09-30 $1,347,364 9,050
2020-06-30 $1,305,749 9,285
2020-03-31 $844,608 6,441